# Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray

> **NCT00109486** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 56 (actual)

## Conditions studied

- Rhinitis, Allergic, Perennial and Seasonal

## Interventions

- **DRUG:** GW685698X

## Key facts

- **NCT ID:** NCT00109486
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2016-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00109486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00109486, "Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00109486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*